Improvement of industry-applied rifamycin B-producing strain, Amycolatopsis mediterranei, by rational screening

Journal of General and Applied Microbiology

Volumn 48, Issue 6, 2002, Pages 329-334

  Jin, Zhi Hua ^a   Lin, Jiang Ping ^a   Xu, Zhi Nan ^a   Cen, Pei Lin ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Amycolatopsis mediterranei; P hydroxybenzoic acid; Propionate; Rational screening; Rifamycin B; Tryptophan

Indexed keywords

4 HYDROXYBENZOIC ACID; AROMATIC AMINO ACID; PROPIONIC ACID; RIFAMYCIN B;

ARTICLE; BACTERIAL STRAIN; BATCH FERMENTATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG INDUSTRY; DRUG SYNTHESIS; GENE MUTATION; INHIBITION KINETICS; NOCARDIA; NOCARDIA MEDITERRANEA; NONHUMAN; SCREENING TEST;

ACTINOMYCETALES; AMINO ACIDS, AROMATIC; BIOTECHNOLOGY; CULTURE MEDIA; FERMENTATION; MUTATION; PARABENS; PROPIONATES; RIFAMYCINS; TRYPTOPHAN; ULTRAVIOLET RAYS;

AMYCOLATOPSIS; AMYCOLATOPSIS MEDITERRANEI; BACTERIA (MICROORGANISMS); NOCARDIA;

EID: 0036977773     PISSN: 00221260     EISSN: None     Source Type: Journal    
DOI: 10.2323/jgam.48.329     Document Type: Article

References (16)

1. Chen, J. M. and Xu, L. T. (1991) Analysis of Antibiotic Industry, Chinese Press of Pharmaceutical Science, Beijing, pp. 126-134.
2. Ghisalba, O., Auden, J. A. L., Schupp, T., and Nüesch, J. (1984) The rifamycins: properties, biosynthesis, and fermentation. In Biotechnology of Industrial Antibiotics, ed. by Vandamme, E. J., Dekker, New York/Basel, pp. 281-327.
3. Ghisalba, O. and Nüesch, J. (1978a) A genetic approach to the biosynthesis of the rifamycin-chromophore in Nocardia mediterranei. I. Isolation and characterization of a pentose-excreting auxotrophic mutant of Nocardia mediterranei with drastically reduced rifamycin-production. J. Antibiot., 31, 202-214.
4. Ghisalba, O. and Nüesch, J. (1978b) A genetic approach to the biosynthesis of the rifamycin-chromophore in Nocardia mediterranei. II. Isolation and characterization of a shikimate excreting auxotrophic mutant of Nocardia mediterranei with normal rifamycin-production. J. Antibiot., 31, 215-225.
5. Ghisalba, O. and Nüesch, J. (1981) A genetic approach to the biosynthesis of the rifamycin-chromophore in Nocardia mediterranei. IV. Identification of 3-amino-5-hydroxybenzoic acid as a direct precursor of the seven-carbon amino starter-unit. J. Antibiot., 34, 67-71.
6. Gu, W. L., Xia, T. H., and Jiao, R. S. (1988) Regulatory effects of terminal products and intermediates of aromatic pathway on rifamycin biosynthesis in Nocardia mediterranei. Acta Microbiol. Sinica, 28, 56-61.
7. Kibby, J. J., McDonald, I. A., and Richards, R. W. (1980) 3-Amino-5-hydroxybenzoic acid as a key intermediate in asamycin and maytansinoid biosynthesis. J. Chem. Soc. Chem. Commun., 1980, 768-769.
8. Lancini, G. and Carvelieri, B. (1997) Rifamycins. In Biotechnology of Antibiotics, 2nd ed., ed. by Strohl, W. R., Dekker, New York, pp. 521-549.
9. Leblihi, A., Germain, P., and Lefebvre, G. (1987) Phosphate repression of cephamycin and clavulanic acid production by Streptomyces clavuligerus. Appl. Microbiol. Biotechnol., 28, 44-51.
10. Oppolzer, W. and Prelog, V. (1973) On the constitution and configuration of rifamycin B, O, S and SV. Helv. Chim. Acta, 56, 2287-2314.
11. Rinehart, K. L., Jr. and Shield, L. S. (1976) Chemistry of the ansamycin antibiotics. Fortschr. Chem. Org. Naturst., 33, 231-307.
12. Sensi, P., Margalis, P., and Timbal, M. T. (1959) Rifamycin, a new antibiotic: preliminary report. Farmaco. Ed. Sci., 14, 146-147.
13. Sensi, P. and Thiemann, J. E. (1967) Production of rifamycins. Prog. Ind. Microbiol., 6, 21-59.
14. Sepkowitz, K. A., Rafalli, J., Riley, L., Kiehn, T. E., and Armstrong, D. (1995) Tuberculosis in the AIDS era. Clin. Microbiol. Rev., 8, 180-199.
15. 13C]glycerate into the chromophore of rifamycin S. FEBS Lett., 49, 233-236.
16. Xia, T. H. and Chiao, J. S. (1989) Regulation of the biosynthetic pathway of aromatic amino acids in Nocardia mediterranei. Biochim. Biophys. Acta, 991, 6-11.